Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 1:27 AM
NCT ID:
NCT06846593
Eligibility Criteria:
Inclusion Criteria:
1. Patients diagnosed with ECRB tendinopathy as determined by radiographic assessment or ultrasound imaging.
2. Patients age 18-65
3. Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
4. Patients who are willing and able to sign corresponding research subject consent form.
Exclusion Criteria:
1. Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
2. Patient has severe medical condition, including recent myocardial infarction, unstable angina, heart failure, severe anemia
3. Patient has had prior surgical treatment of the elbow in the last 5 years or injection treatment(s) in the last 2 years
4. Patient has complete tear of ECRB tendon or other surgical indication
5. Patient has chronic pain conditions unrelated to elbow condition
6. Patient has auto-immune or auto-inflammatory diseases
7. Patient has used tobacco within the last 90 days
8. Patient is not within the ages of 18-65
9. Patient has a history of metabolic disorders
10. Patient has an active infection (local or systemic)
11. Patient is unwilling or unable to sign the corresponding research subject consent form
12. Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06846593
Study Brief:
Protocol Section:
NCT06846593